Evaluation treatment with biologicals in severe asthma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24843

Enrollment

150

Registered

2017-10-14

Start date

2016-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe asthma, biological

Interventions

Prospective evaluation of patients with severe asthma treated with biologicals.

Eligibility

Inclusion criteria

Inclusion criteria: Patients with severe asthma treated with biologicals

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Patient characteristics / biomarkers as predictors of response in treatment with biologicals in severe asthma	—

Secondary

Measure	Time frame
- The relation between the most useful parameters in response evaluation and the different biologicals / patient characteristics. - The time to respons; the most appropriate time for respons evaluation, relation with patient characteristics (early and late responders), differences between the biologicals and response parameters. - The outcome of treatment with biologicals on medium and longterm in severe asthma. - The effect of treatment with biologicals on ENT-symptoms; parameters as predictors of response.	—

Measure

Time frame

- The relation between the most useful parameters in response evaluation and the different biologicals / patient characteristics. - The time to respons; the most appropriate time for respons evaluation, relation with patient characteristics (early and late responders), differences between the biologicals and response parameters. - The outcome of treatment with biologicals on medium and longterm in severe asthma. - The effect of treatment with biologicals on ENT-symptoms; parameters as predictors of response.

—

Contacts

Public ContactA. ten Brinke

Medical Centre Leeuwarden

a.ten.brinke@znb.nl058-2866775

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)